CLAC binds to aggregated Aβ and Aβ fragments, and attenuates fibril elongation

Biochemistry

Volumn 44, Issue 47, 2005, Pages 15602-15609

  Kakuyama, Hiroyoshi ^b,c   Soderberg, Linda ^c   Horigome, Kazuhiko ^a   Winblad, Bengt ^c   Dahlqvist, Camilla ^c   Näslund, Jan ^c   Tjernberg, Lars O ^c  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Novum ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CLAC BINDS; FIBRIL ELONGATION; IMMUNOASSAY; MOLECULAR INTERACTIONS; NEUROPATHOLOGICAL FEATURES;

BIOCHEMISTRY; IMMUNOLOGY; PROTEINS; RESONANCE; SPECTROSCOPY;

DISEASES;

AMYLOID; AMYLOID BETA PROTEIN; COLLAGENOUS AMYLOID PLAQUE COMPONENT PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IMMUNOASSAY; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; SOLID; SPECTROSCOPY; SURFACE PLASMON RESONANCE;

ALZHEIMER DISEASE; AMINO ACIDS, BASIC; AMYLOID BETA-PROTEIN; BINDING SITES; DIMERIZATION; HUMANS; IMMUNOASSAY; KINETICS; NON-FIBRILLAR COLLAGENS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; SURFACE PLASMON RESONANCE;

EID: 28244495950     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi051263e     Document Type: Article

References (36)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's Disease: Progress and problems on the road to therapeutics, Science 297, 353-356.
2. Sisodia, S. S., and St George-Hyslop, P. H. (2002) y-Secretase, notch, Aβ and Alzheimer's disease: Where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290.
3. Selkoe, D. J. (2002) Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease, J. Clin. Invest. 110, 1375-1381.
4. St George-Hyslop, P. H. (2000) Molecular genetics of Alzheimer's disease, Biol. Psychol. 47, 183-199.
5. Hardy, J. (1997) Amyloid, the presenilins and Alzheimer's disease, Trends Neurosci. 20, 154-159.
6. Barbiero, L., Benussi, L., Ghidoni, R., Alberici, A., Russo, C., Schettini, G., Pagano, S. F., Parati, E. A., Mazzoli, F., Nicosia, F., Signorini, S., Feudatari, E., and Binetti, G. (2003) BACE-2 is overexpressed in Down's syndrome, Exp. Neurol. 182, 335-345.
7. Gotz, J., Schild, A., Hoerndli, F., and Pennanen, L. (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: Insight from transgenic mouse and tissue-culture models, Int. J. Dev. Neurosci. 22, 453-465.
8. Stoltzner, S. E., Grenfell, T. J., Mon, C., Wisniewski, K. E., Wisniewski, T. M., Selkoe, D. J., and Lemere, C. A. (2000) Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease, Am. J. Pathol. 156, 489-499.
9. Mann, D. M. (1989) Cerebral amyloidosis, ageing and Alzheimer's disease: A contribution from studies on Down's syndrome, Neurobiol. Aging 10, 397-399.
10. Castillo, G. M., Ngo, C., Cummings, J., Wight, T. N., and Snow, A. D. (1997) Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability, J. Neurochem. 69, 2452-2465.
11. Snow, A. D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T. N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am. J. Pathol. 133, 456-463.
12. Webster, S., Glabe, C., and Rogers, J. (1995) Multivalent binding of complement protein C1Q to the amyloid β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation, Biochem. Biophys. Res. Commun. 217, 869-875.
13. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res. 541, 163-166.
14. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., and Hyman, B. T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann. Neural. 41, 17-24.
15. Raber, J., Huang, Y., and Ashford, J. W. (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology, Neurobiol. Aging 25, 641-650.
16. Palu, E., and Liesi, P. (2002) Differential distribution of laminins in Alzheimer disease and normal human brain tissue, J. Neurosci. Res. 69, 243-256.
17. Holtzman, D. M. (2004) In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology, J. Mol. Neurosci. 23, 247-254.
18. Hashimoto, T., Wakabayashi, T., Watanabe, A., Kowa, H., Hosoda, R., Nakamura, A., Kanazawa, I., Arai, T., Takio, K., Mann, D. M., and Iwatsubo, T. (2002) CLAC: A novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV, EMBO J. 21, 1524-1534.
19. Schmidt, M. L., Saldo, T. C., Lee, V. M., and Trojanowski, J. Q. (1999) Spatial relationship of AMY protein deposits and different species of Aβ peptides in amyloid plaques of the Alzheimer disease brain, J. Neuropathol. Exp. Neurol. 58, 1227-1233.
20. Lemere, C. A., Grenfell, T. J., and Selkoe, D. J. (1999) The AMY antigen co-occurs with Aβ and follows its deposition in the amyloid plaques of Alzheimer's disease and Down syndrome, Am. J. Pathol. 155, 29-37.
21. Söderberg, L., Zhukareva, V., Bogdanovic, N., Hashimoto, T., Winblad, B., Iwatsubo, T., Lee, V. M., Trojanowski, J. Q., and Näslund, J. (2003) Molecular identification of AMY, an Alzheimer disease amyloid-associated protein, J. Neuropathol. Exp. Neurol. 62, 1108-1117.
22. Franzke, C.-W., Bruckner, P., and Bruckner-Tuderman, L. (2005) Collagenous transmembrane proteins: Recent insights into biology and pathology, J. Biol. Chem. 280, 4005-4008.
23. Kowa, H., Sakakura, T., Matsuura, Y., Wakabayashi, T., Mann, D. M., Duff, K., Tsuji, S., Hashimoto, T., and Iwatsubo, T. (2004) Mostly separate distributions of CLAC- versus Aβ40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of β-amyloid deposits, Am. J. Pathol. 165, 273-281.
24. Osada, Y., Hashimoto, T., Nishimura, A., Matsuo, Y., Wakabayashi, T., and Iwatsubo, T. (2005) CLAC binds to amyloid β peptides through the positively-charged amino acid cluster within the collagen domain 1 and inhibits formation of amyloid fibrils, J. Biol. Chem. 280, 8596-8605.
25. Söderberg, L., Dahlqvist, C., Kakuyama, H., Thyberg, J., Ito, A., Winblad, B., Näslund, J., and Tjernberg, L. O. (2005) Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates, FEBS J. 272, 2231-2236.
26. Aguilar, M. I., and Small, D. H. (2005) Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in Alzheimer's disease research, Neurotoxic. Res. 7, 17-27.
27. Söderberg, L., Kakuyama, H., Moller, A., Ito, A., Winblad, B., Tjernberg, L. O., and Näslund, J. (2005) Characterization of the Alzheimer's Disease-associated CLAC protein and identification of an amyloid β-peptide-biriding site, J. Biol. Chem. 280, 1007-1015.
28. Webster, S., Bonnell, B., and Rogers, J. (1997) Charge-based binding of complement component C1q to the Alzheimer amyloid β-peptide, Am. J. Pathol. 150, 1531-1536.
29. Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand, J. Biol. Chem. 271, 8545-8548.
30. Tjernberg, L. O., Callaway, D. J., Tjernberg, A., Hahne, S., Lilliehöök, C., Terenius, L., Thyberg, J., and Nordstedt, C. (1999) A molecular model of Alzheimer amyloid β-peptide fibril formation, J. Biol. Chem. 274, 12619-12625.
31. Tjernberg, L. O., Tjernberg, A., Bark, N., Shi, Y., Ruzsicska, B. P., Bu, Z., Thyberg, J., and Callaway, D. J. (2002) Assembling amyloid fibrils from designed structures containing a significant amyloid β-peptide, Biochem. J. 366, 343-351.
32. Cannon, M. J., Williams, A. D., Wetzel, R., and Myszka, D. G. (2004) Kinetic analysis of β-amyloid fibril elongation, Anal. Biochem. 328, 67-75.
33. Hasegawa, K., Ono, K., Yamada, M., and Naiki, H. (2002) Kinetic modeling and determination of reaction constants of Alzheimer's β-amyloid fibril extension and dissociation using surface plasmon resonance, Biochemistry 41, 13489-1398.
34. Shuvaev, V. V., and Siest, G. (1996) Interaction between human amphipathic apolipoproteins and amyloid β-peptide: Surface plasmon resonance studies, FEBS Lett. 383, 9-12.
35. Wood, S. J., Wetzel, R., Martin, J. D., and Hurle, M. R. (1995) Prolines and amyloidogenicity in fragments of the Alzheimer's peptide βIA4, Biochemistry 34, 724-730.
36. Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., and Rydel, R. E. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death, J. Neurosci. 25, 1071-1080.